Medinice B+Rsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Medinice B+R develops technologies for cardiology and cardiac surgery, including PacePress, CoolCryo and AtriClamp. CoolCryo received FDA clearance for U.S. market entry, and its clinical investigation and six-month patient follow-up have been completed.
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 153 days for 2020).
- 202507/07/2026
- 202414/07/2025
- 202312/07/2024
- 202204/07/2023
- 202130/09/2022
- 202017/03/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Electrotherapy devices
- Cardiac ablation devices
- Left atrial appendage clamps
- Diagnostic catheters
- Therapeutic catheters
Website technology
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 7,100 | $95,894.11 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-04-01.
13 1020 1068 0000 1702 0365 6493
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $111,733.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 30, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Rzeszowska Agencja Rozwoju Regionalnego S.A. | |
| Jul 1, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Rzeszowska Agencja Rozwoju Regionalnego S.A. | |
| Jul 1, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Rzeszowska Agencja Rozwoju Regionalnego S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| CBSsp. z o.o. | $55,382.59 | carbonblack.solutions | ||
| Orbital Matter Polandsp. z o.o. | $52,448.24 | orbital-matter.com | ||
| Escilabsp. z o.o. | $52,338.73 | escilab.com | ||
| USE WasteP.S.A. | $49,849.71 | usewaste.eu | ||
| Lightlogsp. z o.o. | $44,623.05 | lightlog.eu | ||
| Nevomo Pesp. z o.o. | $43,412.25 | nevomo.tech | ||
| Cobant sp. z o.o.sp. k. | $39,911.08 | cobant.eu | ||
| HI Orthoticssp. z o.o. | $39,377.31 | hiorthotics.com | ||
| Explo Solutionsp. z o.o. | $38,911.62 | explosolution.com | ||
| Edoktor24 Servicessp. z o.o. | $34,089.64 | edoktor24.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-08-25 | Address change (954, 36-002, Jasionka → Ul. Stefana Kazimierza Hankiewicza 2, 02-103, Warszawa) | |
| 2020-10-27 | Share capital increase (5,000.00 PLN → 355,000.00 PLN) | |
| 2018-06-05 | Address change (Al. Tadeusza Rejtana 20, 35-310, Rzeszów → 954, 36-002, Jasionka) | |
| 2015-06-11 | Address change (Przyokopowa 33, 01-208, Warszawa → Al. Tadeusza Rejtana 20, 35-310, Rzeszów) | |
| 2015-06-11 | PKD change (Removed: 8 codes) |
FAQ
Last updated: 2026-10-07